Adenocarcinoma clinical trials at UC Irvine
2 research studies open to eligible people
Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
open to eligible people ages 18 years and up
This is a pilot clinical trial determining the effect of a Methionine-reduced diet on serum levels in subjects with solid tumors. These are subjects who will receive systemic standard of care cancer therapy.
Orange, California
Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma
open to eligible people ages 18 years and up
This is a 2-part, Phase 2 study to evaluate the safety, tolerability, dosing, pharmacokinetics (PK), and efficacy of relacorilant in combination with nab-paclitaxel and gemcitabine in chemotherapy-naïve patients with metastatic pancreatic adenocarcinoma (PDAC).
Orange, California and other locations
Our lead scientists for Adenocarcinoma research studies include Zhaohui Liao Arter Farshid Dayyani.
Last updated: